Cotransplantation of ex vivo expanded progenitors with nonexpanded cord blood cells improves platelet recovery

Stem Cells and Development

Volumn 21, Issue 17, 2012, Pages 3209-3219

  Imond, Hélène ^a,b   Boyer, Lucie ^a   Roy, Denis Claude ^c,d   Pineault, Nicolas ^a,b,e  

^a HÉMA QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD34 SELECTION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MEGAKARYOBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL EXPANSION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPOIESIS;

ADULT; ANIMALS; ANTIGENS, CD34; BLOOD PLATELETS; BONE MARROW; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HOT TEMPERATURE; HUMANS; MEGAKARYOCYTE PROGENITOR CELLS; MICE; MICE, INBRED NOD; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEIN IIB; THROMBOPOIESIS;

MURINAE;

EID: 84869078122     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0142     Document Type: Article

References (41)

1. Brunstein CG, DC Setubal and JE Wagner. (2007). Expanding the role of umbilical cord blood transplantation. Br J Haematol 137:20-35. (Pubitemid 46426403)
2. Dahlberg A, C Delaney and ID Bernstein. (2011). Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117:6083-6090.
3. Barker JN, DJ Weisdorf, TE DeFor, BR Blazar, PB McGlave, JS Miller, CM Verfaillie and JE Wagner. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343-1347. (Pubitemid 40170912)
4. Brunstein CG, JA Gutman, DJ Weisdorf, AE Woolfrey, TE Defor, TA Gooley, MR Verneris, FR Appelbaum, JE Wagner and C Delaney. (2010). Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116:4693-4699.
5. Ballen KK, TR Spitzer, BY Yeap, S McAfee, BR Dey, E Attar, R Haspel, G Kao, D Liney, et al. (2007). Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13:82-89. (Pubitemid 46044092)
6. Bertolini F, M Battaglia, P Pedrazzoli, GA Da Prada, A Lanza, D Soligo, L Caneva, B Sarina, S Murphy, T Thomas and GR della Cuna. (1997). Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679-2688. (Pubitemid 27172552)
7. Kogler G,WNurnberger, J Fischer, T Niehues, T Somville, U Gobel and P Wernet. (1999). Simultaneous cord blood transplantation of ex vivo expanded together with nonexpanded cells for high risk leukemia. Bone Marrow Transplant 24:397-403. (Pubitemid 29403446)
8. Fernandez MN, A Granena, I Millan, C Regidor, R Cabrera, S Querol and J Garcia. (2000). Evaluation of engraftment of ex vivo expanded cord blood cells in humans. Bone Marrow Transplant 25 Suppl 2:S61-S67. (Pubitemid 30433626)
9. Pecora AL, P Stiff, A Jennis, S Goldberg, R Rosenbluth, P Price, KL Goltry, J Douville, RD Armstrong, AK Smith and RA Preti. (2000). Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 25:797-799. (Pubitemid 30189523)
10. Shpall EJ, R Quinones, R Giller, C Zeng, AE Baron, RB Jones, SI Bearman, Y Nieto, B Freed, et al. (2002). Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8:368-376.
11. Jaroscak J, K Goltry, A Smith, B Waters-Pick, PL Martin, TA Driscoll, R Howrey, N Chao, J Douville, et al. (2003). Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101:5061-5067. (Pubitemid 36857774)
12. Paquette RL, ST Dergham, E Karpf, HJ Wang, DJ Slamon, L Souza and JA Glaspy. (2000). Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 96:2385-2390.
13. McNiece I, R Jones, SI Bearman, P Cagnoni, Y Nieto, W Franklin, J Ryder, A Steele, J Stoltz, et al. (2000). Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96:3001-3007.
14. Prince HM, PJ Simmons, G Whitty, DP Wall, L Barber, GC Toner, JF Seymour, G Richardson, R Mrongovius and DN Haylock. (2004). Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol 126:536-545. (Pubitemid 39093096)
15. Boiron JM, B Dazey, C Cailliot, B Launay, M Attal, F Mazurier, IK McNiece, Z Ivanovic, J Caraux, G Marit and J Reiffers. (2006). Large-scale expansion and transplantation of CD34 (+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 46:1934-1942. (Pubitemid 44631601)
16. Delaney C, S Heimfeld, C Brashem-Stein, H Voorhies, RL Manger and ID Bernstein. (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 16:232-236.
17. De Lima M, S Robinson, J McMannis, AM Alousi, RM Saliba, M Munsell, P Kebriaei, C Hosing, S Parmar, et al. (2010). Mesenchymal stem cell (MSC) based cord blood (CB) expansion (Exp) leads to rapid engraftment of platelets and neutrophils. Blood 116:362.
18. Proulx C, L Boyer, DR Hurnanen and R Lemieux. (2003). Preferential ex vivo expansion of megakaryocytes from human cord blood CD34 + -enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res 12:179-188. (Pubitemid 36529569)
19. Mattia G, L Milazzo, F Vulcano, M Pascuccio, G Macioce, HJ Hassan and A Giampaolo. (2008). Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34 + cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol 36:244-252.
20. Pineault N, V Cortin, L Boyer, A Garnier, A Robert, C Therien and DC Roy. (2011). Individual and synergistic cytokine effects controlling the expansion of cord blood CD34 + cells and megakaryocyte progenitors in culture. Cytotherapy 13:467-480.
21. Cortin V, A Garnier, N Pineault, R Lemieux, L Boyer and C Proulx. (2005). Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol 33:1182-1191. (Pubitemid 41416966)
22. Feng Y, L Zhang, ZJ Xiao, B Li, B Liu, CG Fan, XF Yuan and ZC Han. (2005). An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol 33:1537-1543. (Pubitemid 41773854)
23. Tijssen MR, PB van Hennik, F di Summa, JJ Zwaginga, CE van der Schoot and C Voermans. (2008). Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice. Leukemia 22:203-208.
24. van Hensbergen Y, LF Schipper, A Brand, MC Slot, M Welling, AJ Nauta and WE Fibbe. (2006). Ex vivo culture of human CD34 + cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol 34:943-950.
25. Cxelebi B, D Mantovani and N Pineault. (2011). Irradiated mesenchymal stem cells improve the ex vivo expansion of hematopoietic progenitors by partly mimicking the bone marrow endosteal environment. J Immunol Methods 370:93-103.
26. Proulx C, N Dupuis, I St-Amour, L Boyer and R Lemieux. (2004). Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng 88:675-680. (Pubitemid 40775323)
27. Boyer L, A Robert, C Proulx and N Pineault. (2008). Increased production of megakaryocytes near purity from cord blood CD34 + cells using a short two-phase culture system. J Immunol Methods 332:82-91.
28. Pineault N and L Boyer. (2011). Cellular-based therapies to prevent or reduce thrombocytopenia. Transfusion 51 Suppl 4:72S-81S.
29. Salles II, T Thijs, C Brunaud, SF De Meyer, J Thys, K Vanhoorelbeke and H Deckmyn. (2009). Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34 (+) cells are functionally active in an ex vivo flow model of thrombosis. Blood 114:5044-5051.
30. Bonnet D, M Bhatia, JC Wang, U Kapp and JE Dick. (1999). Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 23:203-209. (Pubitemid 29078332)
31. Laughlin MJ, M Eapen, P Rubinstein, JE Wagner, MJ Zhang, RE Champlin, C Stevens, JN Barker, RP Gale, et al. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275. (Pubitemid 39552742)
32. Cheung AM, D Leung, S Rostamirad, K Dhillon, PH Miller, R Droumeva, RR Brinkman, D Hogge, DC Roy and CJ Eaves. (2012). Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation. Blood 119:3431-3439.
33. Liu ZJ, J Italiano, Jr., F Ferrer-Marin, R Gutti, M Bailey, B Poterjoy, L Rimsza and M Sola-Visner. (2011). Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 117:4106-4117.
34. Barker JN, DJ Weisdorf, TE DeFor, BR Blazar, PB McGlave, JS Miller, CM Verfaillie and JE Wagner. (2005). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:1343-1347. (Pubitemid 40170912)
35. Barker JN, DJ Weisdorf and JE Wagner. (2001). Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 344:1870-1871. (Pubitemid 32538709)
36. Weinreb S, JC Delgado, OP Clavijo, EJ Yunis, L Bayer-Zwirello, L Polansky, L Deluhery, G Cohn, JT Yao, et al. (1998). Transplantation of unrelated cord blood cells. Bone Marrow Transplant 22:193-196. (Pubitemid 28375660)
37. Perez LE, O Alpdogan, JH Shieh, D Wong, A Merzouk, H Salari, RJ O'Reilly, MR van den Brink and MA Moore. (2004). Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp Hematol 32:300-307. (Pubitemid 38328536)
38. Piper JT, MP Gelderman and JG Vostal. (2007). In vivo recovery of human platelets in severe combined immunodeficient mice as a measure of platelet damage. Transfusion 47:1540-1549.
39. Pineault N, J-F Boucher, M-P Cayer, L Palmqvist, L Boyer, R Lemieux and C Proulx. (2008). Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev 17:483-494.
40. Ong LM, X Fan, PP Chu, FP Gay, S Bari, JM Ang, Z Li, J Chen, SK Lim, RM Bunte and WY Hwang. (2012). Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures. Biol Blood Marrow Transplant 18:674-682.
41. Guenechea G, JC Segovia, B Albella, M Lamana, M Ramirez, C Regidor, MN Fernandez and JA Bueren. (1999). Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34 (+) cord blood cells. Blood 93:1097-1105. (Pubitemid 29067876)